Advanced Medical Solutions Group (AMS)

Sector:

Health Care

Index:

FTSE AIM 50

 210.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 258.00
  • 52 Week Low: 177.20
  • Currency: UK Pounds
  • Shares Issued: 217.41m
  • Volume: 0
  • Market Cap: £457.65m
  • RiskGrade: 156

Friday broker round-up UPDATE

Date: Friday 24 Oct 2014

LONDON (ShareCast) - Advanced Medical Solutions: Oriel initiates with a target price of 135p and a buy recommendation.
African Barrick Gold: JP Morgan moves target price from 300p to 310p maintaining its overweight rating. Canaccord Genuity reduces target price from 330p to 275p keeping a buy recommendation. Numis moves target price from 270p to 280p and leaves its buy recommendation unaltered. Investec shifts target price from 258p to 262p and maintains a buy recommendation.

Amara Mining: Canaccord Genuity lowers target price from 33p to 28p keeping its buy recommendation.

Avocet Mining: Canaccord Genuity lowers target price from 6p to 4p and retains a sell recommendation.

Balfour Beatty: Berenberg cuts target price from 290p to 250p staying with its buy recommendation.

Britvic: Numis lowers target price from 765p to 763p, while upgrading to add.

Centamin: Canaccord Genuity cuts target price from 74p to 65p and keeps a speculative buy recommendation.

Dart Group: Canaccord Genuity ups target price from 288p to 295p and leaves its buy recommendation unchanged.

Debenhams: Deutsche Bank lowers target price from 76p to 75p retaining its hold recommendation.

Dechra Pharmaceuticals: Oriel upgrades to add with a target price of 775p.

Diamond Corp: Northland downgrades from buy to hold.

Hochschild Mining: JP Morgan shifts target price from 150p to 155p and keeps a neutral rating.

Inchcape: Deutsche Bank moves target price from 700p to 715p and reiterates a buy recommendation.

Lloyds Banking Group: Deutsche Bank shifts target price from 94p to 95p and keeps a buy recommendation.

Minera IRL: Canaccord Genuity lowers target price from 20p to 14p, while its speculative buy recommendation remains unchanged.

Pan African Resources: Canaccord Genuity lowers target price from 18p to 15p and maintains a buy recommendation.

Pearson: Westhouse Securities cuts target price from 1001p to 995p and stays with its sell recommendation.

Petropavlovsk: Canaccord Genuity cuts target price from 70p to 40p, while leaving its speculative buy recommendation unchanged.

Polymetal: Canaccord Genuity reduces target price from 565p to 440p and reiterates a hold recommendation.

Randgold Resources: Canaccord Genuity reduces target price from 5100p to 4100p retaining its hold recommendation.

Reed Elsevier: Berenberg increases target price from 960p to 1005p and keeps a hold recommendation.

Rolls-Royce: Deutsche Bank reduces target price from 860p to 655p maintaining its sell recommendation.

Schroders: JP Morgan reduces target price from 2985p to 2800p leaving its overweight rating unchanged.

Spectris: Investec places its target price (prev.: 2380p) under review, while keeping a buy recommendation.

Tern: Beaufort initiates with a speculative buy recommendation.

Tesco: Deutsche Bank cuts target price from 220p to 180p and retains a hold recommendation. JP Morgan cuts target price from 165p to 145p staying with its underweight rating. Espirito Santo cuts target price from 165p to 145p reiterating its sell recommendation.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AMS Market Data

Currency UK Pounds
Share Price 210.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 258.00
52 Week Low 177.20
Volume 0
Shares Issued 217.41m
Market Cap £457.65m
RiskGrade 156

AMS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.56% below the market average71.56% below the market average71.56% below the market average71.56% below the market average71.56% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Price Trend
31.67% below the market average31.67% below the market average31.67% below the market average31.67% below the market average31.67% below the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average
Income
86.89% below the market average86.89% below the market average86.89% below the market average86.89% below the market average86.89% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Growth
37.71% below the market average37.71% below the market average37.71% below the market average37.71% below the market average37.71% below the market average
72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 2
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AMS Dividends

  Latest Previous
  Final Interim
Ex-Div 30-May-24 28-Sep-23
Paid 21-Jun-24 27-Oct-23
Amount 1.66p 0.70p

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

AMS Key Personnel

CEO A Christopher (Chris) Meredith
CFO Eddie Johnson
Chair Liz Shanahan

Top of Page